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Abstract
Background: Various estimates of the incidence and mortality rate of the acute (adult) respiratory
distress syndrome (ARDS) have been published. The studies that led to those estimates were based
on relatively small patient populations and employed variable diagnostic identifiers of ARDS. The
purpose of this study was to estimate the incidence of ARDS and its mortality rate from a large
database to which refined diagnostic criteria were applied. We conducted a retrospective review of all
hospital discharges over a 4-year period, using screening criteria designed to select patients with
ARDS. Discharges from all acute care hospitals in the state of Maryland were reviewed using a
computer database from the Health Services Cost Review Commission (HSCRC). Patients ≥ 12 years
of age were included. Screening criteria consisted of ICD-9 codes 518.5 and 518.82 cross-referenced
with procedural codes for ventilatory support (96.70, 96.71 and 96.72). Data were normalized to the
number of cases per 100,000 people.
Results: During the 4-year study period there were 2,501,147 hospitalizations. Applying the ICD-9
ARDS criteria yielded lower and upper limits of 159-205, 439-568, 531-694 and 529-720 cases of
ARDS for 1992, 1993, 1994 and 1995, respectively. Normalizing for a population of 5 million yields
yearly lower and upper limit rates of 3.2-4.2, 8.8-11.4, 10.6-13.8 and 10.5-14.2 cases of ARDS per
100,000 people. Mortality upper and lower limit rates based upon the same duration, admissions and
population were 38-49%, 39-52%, 36-47%, and 36-49%, respectively.
Conclusions: The incidence of ARDS in Maryland is in the range of 10-14 cases per 100,000 people.
The ARDS mortality rate is 36% to 52%, similar to that calculated in previous studies.
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Introduction
The acute (adult) respiratory distress syndrome (ARDS)
continues to cause substantial morbidity and mortality in
the USA [1] and worldwide [2–4], but the incidence
remains unclear. The National Heart and Lung Institute
(NHLI) Task Force on Respiratory Distress Syndromes esti-
mated the incidence of ARDS in the USA at 150,000 new
cases per year [1]. The NHLI estimate translates to a pop-
ulation-based figure of 71 per 100,000. A recent prospec-
tive screening evaluation of hospitals in Utah [5] suggested
that the incidence of ARDS is actually 'an order of magni-
tude less than' the NHLI estimate. The authors, Thomsen et
al, estimated lower and upper limits for the incidence to be
4.8 and 8.3 cases of ARDS per 100,000 people. In 1988,
Webster et al[2] calculated the incidence of ARDS in a lim-
ited British population to be 4.5 per 100,000 people, simi-
lar to Thomsen's estimate.
Villar and Slutsky [3] prospectively reviewed the incidence
of ARDS in a controlled population of 703,710 during a 3-
year period on the Canary Islands. Applying two sets of
diagnostic criteria, the investigators found an incidence
ranging from 1.5-3.5 cases per 100,000 people. Angus et
al reported a much higher incidence of 50.7-64.3 per
100,000 people [4]. The Angus study, based on 109,874
hospital admissions from three states, Washington DC and
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national Classification of Diseases, ninth edition (ICD-9),
similar to those employed in the Thomsen study. However,
Angus further refined the ICD-9 coding to include patients
with > 96 h of ventilatory support. Preliminary data from
another ongoing prospective study in a major university
hospital revealed an incidence of ARDS of 25 per 100,000
[6].
The mortality rate associated with ARDS has also been dif-
ficult to quantify. The 1972 report from the NHLI quoted a
range of mortality from 25% with optimal care to 70% in the
absence of treatment. The American-European Consensus
conference report [7] states that the 'published mortality
rate of patients with ARDS varies from 10% to as high as
90%'. An effort to determine international hospital survival
rates was undertaken by Vasilyev et al in 1995 [8]. A survey
of both US and European respiratory ICUs determined that
the survival rate was 33% (mortality 67%) over a 1-year
period. Survival was higher in patients with acute respira-
tory failure secondary to pneumonia (63%) or postshock
lung injury (67%), compared with respiratory failure result-
ing from sepsis (46%). According to Evans et al[6], the
mortality rate is highest among patients with gastric aspira-
tion, pneumonia and sepsis (60%).
In order to establish the incidence and mortality associated
with ARDS in one of the 50 United States (Maryland), a ret-
rospective review of Health Services Cost Review Com-
mission data was undertaken.
Materials and methods
The Health Services Cost Review Commission (HSCRC)
was established by the Maryland General Assembly in
1971 and given the authority to establish hospital rates. To
achieve its rate-setting goals, the HSCRC collects data
from all hospitals in the state. This includes demographic
information, discharge diagnosis by the ICD-9 classification
[9], utilization data such as length of hospital and ICU stay,
and hospital charges. Since the HSCRC is a state agency,
the information is available to the public.
Our methods and criteria were modifications of those used
by Angus [4] and Thomsen [5]. The relevant ICD-9 codes
are shown in Table 1. The HSCRC database was reviewed
in a two-step process. The initial search was for all patients
> 12 years old who were discharged between the begin-
ning of 1992 and end of 1995 with ICD-9 codes 518.5 and
518.82 (Table 2), without additional constraint. The ICD-9
code 518.81 was not searched because its descriptors do
not include ARDS. The second search incorporated the
same ICD-9 codes with the additional mandate of ventila-
tory support (Table 2) (procedural codes 96.70, 96.71 and
96.72, established in 1991). The data were subsequently
stratified into survivors and non-survivors.
The combination of ICD-9 disease and procedure codës
representing the ICD-9 ARDS criteria mandates that the
ARDS patient must meet all of the following criteria:
1. have a code directly indicating ARDS in the ICD-9
description;
2. be on concurrent ventilatory support, and
3. have required ≥ 4 days of ventilatory support unless the
disease was fatal within that time (lower limit), or have
Table 1
Respiratory disease codes from the International Classification of 
Diseases, 9th revision (ICD-9)
518.5 Pulmonary insufficiency following trauma and surgery







Adult respiratory distress syndrome associated










Acute respiratory distress (518.82)
Respiratory arrest (799.1)
Respiratory failure, newborn (770.8)
518.82 Other pulmonary insufficiency, not elsewhere classified
Acute respiratory distress
Acute respiratory insufficiency
Adult respiratory distress syndrome (NEC)
Excludes:
Adult respiratory distress syndrome following trauma
and surgery (518.5)







96.70 Continuous mechanical ventilation of unspecified 
duration
96.71 Continuous mechanical ventilation for < 96 h 
consecutively
96.72 Continuous mechanical ventilation for ≥96 h 
consecutively
NOS = not otherwise specified; NEC = not elsewhere classified.
Available online http://ccforum.com/content/2/1/29required ventilatory support of unspecified duration, survi-
vors and non-survivors (upper limit).
ICD-9 procedure code 96.70 (ventilation support of
unspecified duration) was reviewed to determine potential
error introduced by failure to define ventilator duration.
Population data for the state of Maryland were extracted
from the Statistical Abstract of the United States[10]. The
ARDS incidence estimate was then normalized per
100,000 people in the population base.
Results
For the 4-year period covered by this study, 2,501,147
hospital discharges from the 52 acute care Maryland hos-
pitals were screened. As revealed in Table 3, when ventila-
tory support is not a mandated criterion, a substantial
number of patients are included, representing 15-42% of
the total population of potential ARDS patients. During the
years studied, the numbers of potential ARDS patients with
ICD-9 codes 518.5 or 518.82 alone remained relatively
stable, whereas the numbers of potential ARDS patients
with additional codes indicating ventilatory support
increased three to fourfold in each category. Further, the
ICD-9 procedure code 96.70 (ventilatory support of
Table 2
Two-step search of the HSCRC database
Initial search Additional constraints Second search
518.5 Post-surgical 96.70 Ventilator 518.5 + 96.71
or post-trauma duration
ARDS; survivor NOS
or non-survivor 518.5 + 96.72
518.82 ARDS unrelated 96.71 Ventilator 518.82 + 96.71
to trauma or support < 4 days
surgery;
survivor or 96.72 Ventilator 518.82 + 96.72
non-survivor support > 4 days
NOS = not otherwise specified.
Table 3
Numbers of patients with discharge diagnoses that include ARDS and ventilatory support descriptors
1992 1993 1994 1995
1 Hospital discharges 629,881 621,209 625,020 625,037
2 ICD-9 518.5 only* 217 162 139 161
3 ICD-9 518.82 only* 97 71 69 58
4 518.5 + 96.71†
ventilator < 4 days
(expired/total) 10/35 27/116 32/158 42/179
5 518.5 + 96.72†
ventilator > 4 days 72 245 315 296
6 518.82 + 96.71†
ventilator < 4 days
(expired/total) 9/30 28/68 19/74 24/78
7 518.82 + 96.72†
ventilator > 4 days 68 139 165 167
8 518.5 + 96.70†
ventilator duration 
NOS
0 1 2 3
9 518.82 + 96.70†
ventilator NOS 0 0 5 1
Total 519 802 927 942
NOS = not otherwise specified. *Patients coded for ARDS without further descriptors; †procedure codes 96.70, 96.71 and 96.72 were 
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patient population and is excluded from further
consideration.
By applying the ICD-9 ARDS criteria described above, the
'lower limit' was generated by combining numerators of
lines four and six with lines five and seven from Table 3. The
'upper limit' was generated by combining the denominators
of lines four and six with lines five and seven. The resulting
yearly estimates of ARDS patients in Maryland are shown in
Table 4.
The in-hospital mortality rate by year and ICD-9 coding is
shown in Table 5. Despite substantial increases in the
number of patients with ARDS, the associated mortality
rate has remained essentially unchanged.
Discussion
In attempting to define the 'magnitude of the problem', the
NHLI task force conceded that ARDS was a relatively new
syndrome (in 1971) and had not been included in the code
of disease classification that was in existence at that time;
they also conceded that relatively few physicians could
make the diagnosis of ARDS reliably. Therefore, 'valid
statistical data to document the magnitude of the health
problem due to (A)RDS [are] virtually unobtainable' [1].
To estimate the frequency of ARDS, 'some members' of the
NIH panel collected data 'on their own', representing 4650
hospital beds. During a 1-year period, 3200 patients with
acute respiratory failure were seen, 'roughly one half classi-
fied as [having] (A)RDS'. In addition, six military hospitals
were reviewed (duration undefined), representing 127,000
admissions and 1295 cases of 'acute respiratory failure', an
incidence of approximately 1%. In neither case were the cri-
teria to define ARDS stated explicitly nor was the overall
population base defined. In addition, the NHLI task force
results did not define the incidence of ARDS as a function
of population.
Table 4
Estimated ARDS incidence in Maryland, calculated from the application of ICD-9 ARDS criteria
1992 1993 1994 1995
Population* 4914 4958 5006 5050‡
ARDS, all inclusive† 519 802 927 942
Cases/100,000 10.6 16.2 18.5 18.6
ICD-9 ARDS criteria 159 439 513 529
Lower limit
ICD-9 ARDS criteria 205 568 694 720
Upper limit
Cases/100,000
Lower limit 3.2 8.8 10.6 10.5
Upper limit 4.2 11.4 13.8 14.2
*Expressed in thousands; †represents data from the initial search that did not mandate ventilatory support; ‡extrapolated from two previous years' 
growth rates (0.8% and 0.96%).
Table 5
Hospital-based mortality rate of patients with ICD-9 ARDS criteria
ICD-9 code Ventilation 1992 1993 1994 1995
(days)
518.5 < 4* 10/35 27/116 32/158 42/179
518.82 < 4* 9/30 28/68 19/74 24/78
518.5 > 4† 30/72 105/245 130/315 116/296
518.82 > 4† 29/68 67/139 69/165 79/167
Total expired 78 227 250 216
(all categories)
Mortality
Upper limit 49% 52% 47% 49%
Lower limit 38% 39% 36% 36%
Data is presented in fractional form as survivors over total patients within each category. *ICD-9 code 96.71; †ICD-9 code 96.72.
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between 1 September 1989 and 31 August 1990. Rela-
tively accepted criteria to diagnose ARDS [arterial/alveolar
oxygen ratio < 0.2, bilateral infiltrates, pulmonary capillary
wedge pressure (PCWP) < 15 and static compliance (Cs)
< 50 ml/cmH2O] were applied to patients from these six
facilities. The actual mechanism or process of screening is
undefined. The remaining 34 Utah hospitals were screened
via the Utah Hospital Association registry, using discharge
diagnoses identified by ICD-9 codes [5]. Codes 518.5,
518.81 and 518.82 (Table 1) were used as the sole indica-
tors of ARDS. No further diagnostic classifiers were
applied. Considerable effort was expended to ensure that
the direct hospital 'screened' data were comparable to the
Utah Hospital Association data. These two sources and
types of data were then combined to develop a single data-
base. Additionally, multiple estimates were applied to
account for the transit of patients into and out of the state.
Ultimately, Thomsen et al estimated an incidence of ARDS
between 4.8 and 8.3 per 100,000 in a mostly rural state
with a population of 1.7 million.
The commonly quoted study by Villar and Slutsky suggests
an incidence of ARDS ranging from 1.5 to 3.5 cases per
100,000. This was a prospective 3-year study performed in
the early to mid 1980s and based at a single referral hospi-
tal in the Canary Islands. All patients requiring mechanical
ventilation, other than for anesthesia or immediate postop-
erative care, were believed to be hospitalized at this single
referral center. The population base was estimated at
700,000. Although the study indicates a total of 23,920
admissions per year to all hospitals, the number of admis-
sions to the study facility is not given; however, 1997
patients were admitted to the referral center's ICU. The
incidence statistic is based on, at most, 74 patients with
ARDS.
Webster, Cohen and Nunn [8] estimated the incidence of
ARDS in the United Kingdom at 4.5 per 100,000. Their
study was retrospective and based on data from 15 hospi-
tals in a region with a population of 3.6 million. Data were
collected from questionnaires sent to 'consultants' in
charge of various ICUs. The response rate to the question-
naire was 88%. It is unclear whether information submitted
by the consultants was based on objective hospital data or
on recollection.
Angus et al[4] estimated the US national incidence of
ARDS at 50.7-64.3 per 100,000. The Angus definition of
ARDS and mechanism of acquiring data were essentially
identical to those used in our study, with the addition of
ICD-9 code 518.81 (ie respiratory failure not otherwise
specified, acute, acute and chronic or chronic, and exclud-
ing acute respiratory distress). Specifically, the ICD-9
codes 518.5, 518.81 and 518.82 had to be further quali-
fied with survival for > 96 h on mechanical ventilation or
death within that period. The substantially higher incidence
of ARDS in the study by Angus et al probably reflects the
inclusion of ICD-9 code 518.81. Characteristics of recent
studies are compared in Table 6.
During the study period, the population base for Maryland
remained relatively stable at approximately 5 million, but the
incidence of ARDS appeared to rise. Review of the data in
Table x3 suggests that, during the study interval, fewer
patients were discharged with diagnostic codes limited to
518.5 or 518.82 and that gradually more patients had
added diagnostic procedure codes for ventilatory support.
We suspect, therefore, that the incidence of ARDS may not
be changing, but rather the use of the procedure codes
may be improving. Over the 4-year interval studied, the
population of patients meeting our ICD-9 ARDS criteria
appears to have leveled off at approximately 500 to 700
patients per 5 million people.
The rationale for our selection of the specific ICD-9
descriptor pattern is as follows. Patients with ARDS, by
definition, require ventilatory support; therefore, the combi-
nation of diagnostic criteria and ventilatory support is
mandatory.
Fifty percent fewer patients fitted the ICD-9 ARDS criteria
during the second search employing ICD-9 code 518.5 or
518.82 with the requirement of concurrent ventilatory sup-
port (compared with ICD-9 code 518.5 or 518.82 alone).
Other authors [11] have suggested that applying only the
ICD-9 codes of 518.5, 518.81, and 518.82 is adequately
specific to describe ARDS. Our data indicate significant
lack of specificity when coding only one descriptor.
Second, clinically, ARDS is a relatively long-term disease
and highly unlikely to resolve within 4 days. Evans [6]
observed a duration of ARDS of 3.8 to 12.2 days. Other
investigators [12] noted median survival times of 13 days,
suggesting significantly more than 4 days of ventilatory
support. On the other hand, ARDS may be a rapidly fulmi-
nant disease [13]. Montgomery noted that, in a group of 32
patients with ARDS, 10 died within 72 h of onset.
To develop our lower limit, it was assumed that surviving
patients with ICD-9 codes 518.5 and 518.82 who require
fewer than 4 days of ventilatory support were mis-coded or
mis-diagnosed and were, therefore, excluded from primary
consideration. However, since the assumption of 'miscod-
ing or mis-diagnosis' may be inappropriately exclusive, we
developed the 'upper limit', which includes all patients
coded for ARDS but requiring ventilation fewer than 4 days
(survivors and non-survivors).Page 5 of 7
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and 96.72) did not come into existence until October 1991.
As shown in Table 4, there was an apparent 3.3 to 3.5-fold
increase in the incidence of ARDS by the ICD-9 criteria.
We believe this reflects increasing use of the ventilator pro-
cedure codes. In 1994 and 1995, the incidence stabilized,
perhaps reflecting more uniform and complete ICD-9 diag-
nostic and procedural coding.
Our study's inclusion criteria were more restrictive than
those of other studies that employed the ICD-9 coding sys-
tem. Intuitively, more stringent criteria would be expected to
yield fewer patients, all other variables being equal. How-
ever, our criteria yielded higher numbers of ARDS patients
than the less restrictive criteria of Thomsen and Morris. The
Utah study may have underestimated the frequency of
ARDS because of a more limited population base or a
shorter duration of study. Or perhaps the incidence of the
disease is truly lower in a rural environment. On the other
hand, perhaps patient diagnosis and therefore coding was
less rigorous, leading to over-diagnosis in Maryland. Alter-
natively the disease might be more prevalent in a crowded
urban environment.
The weakness of a computer-based data registry using the
ICD-9 coding system is that no true physiological data are
apparent. The first presumption is that knowledgeable clini-
cians will apply similar and reasonable criteria to diagnose
ARDS. Second, it is assumed that record clerks will inter-
pret medical records properly and code discharge diag-
noses correctly. Third, there may be a coding bias designed
to maximize reimbursement rather than correctly describe
the disease entity. Fourth, our ICD-9 ARDS criteria may not
be accepted in the medical community. Therefore, through-
out this report, we have used the phrase 'ICD-9 ARDS cri-
teria' instead of implying absolute certainty that the
described patients truly have ARDS. We offer these criteria
for consideration as a more specific computer-based set of
descriptors. As such, these computer-based estimates of
ARDS could serve for assessment of incidence, financial
planning and impact studies. For instance, based on the
estimated incidence of ARDS of 10.2 to 14.2 per 100,000
and a US population of 260 million (1994), the national inci-
dence would be 27,300 to 36,920 new episodes of ARDS
per year. Furthermore, such population-based ICD-9 statis-
tics may be valuable for the development of tertiary referral
centers for advanced treatment of ARDS. Such estimates,
with lack of direct physiologic data, are not likely to be use-
ful in evaluating specific therapeutic strategies, but may be
useful to monitor trends.
Other assumptions of this study are that all Maryland resi-
dents are treated in hospitals within the state, and that all
patients hospitalized in Maryland are state residents. Obvi-
ously, the hospitalized population is not that distinct,
because Maryland borders other states and the District of
Columbia, which offer a full range of medical care. How-
ever, since Maryland offers all primary, secondary and
tertiary medical services, there is no necessity to leave the
state for such care. The degree of error incurred by our
assumptions is probably small, but unknown.
Finally, our mortality data are well within the middle range of
those documented in other reports. With advanced tech-
nologies to support and treat established ARDS, the asso-
ciated mortality may be declining. However, with other
advanced technologies such as chemotherapeutic agents,
bone marrow transplants and immunosuppressive agents,
the opportunity for ARDS to develop seems greater. The
direction of the mortality rate associated with ARDS will
require long-term study.
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Table 6
Comparison of recent studies evaluating the incidence of ARDS
Study [reference] Population No of hospitals Patient statistic* Duration (years)
Current study 5,000,000 52 2,501,147 4
NIH [1] ? 4650 beds 6 hospitals 3200 127,000 1 (?)
Thomsen [5] 1,720,000 40 LDS hospital 19,050 1
Villar [3] 700,000 1 1997 ICU admissions 3
Webster [2] 3,600,000 15 5636 ICU admissions 1
Angus [4] † † 109,874 admissions 1-2
Evans [6] 741,000 15 1512 ICU admissions 1
*Any statistic that indicates number of patients in the study; †probably large, since the study is multi-regional. LDS = Latter Day Saints.
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